Daniel J. Starks, Director at ABBOTT LABORATORIES (ABT), sold 100,000 shares at $114.84 ($11.3M) on 2022-05-03, disclosed to the SEC on 2022-05-05.
Open-market sale of $11.3M ABT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $112.51 | 16,822 | $1.9M | 16.7% |
| 2 | $112.51 | 16,822 | $1.9M | 16.7% |
| 3 | $113.29 | 27,055 | $3.1M | 27.1% |
| 4 | $113.29 | 27,055 | $3.1M | 27.1% |
| 5 | $114.84 | 6,123 | $703K | 6.2% |
| 6 | $114.84 | 6,123 |
| $703K |
| 6.2% |
| Total | $113.22 avg | 100,000 | $11.3M | 100% |
| Filing → |
| ABT | SELL | 2023-10-30 | $9.4M | — | Filing → |
| ABT | SELL | 2023-07-28 | $11.4M | — | Filing → |
| ABT | SELL | 2023-05-02 | $10.7M | — | Filing → |